Lyra Therapeutics, Inc. (Nasdaq: LYRA) ("Lyra" or the "Company"), a clinical-stage biotechnology company developing long-acting, anti-inflammatory sinonasal ...

The FDA just approved a new cervical cancer screening tool called the Teal Wand. Here's what you need to know about it and ...

The FDA is urging the food industry to phase out artificial food dyes, including Red Dye No. 3, citing potential health risks ...

Longitudinal evaluation of SNOT-22 can distinguish patients with chronic rhinosinusitis with nasal polyps who respond quickly ...

Operating profit / (loss): Operating profit was $10.6 million for the three months ended 31 March 2025, compared to ($48.4) million for the same period in the prior year. The increase of $59 million ...

Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.

Learn more about whether Exact Sciences Corporation or Insmed Incorporated is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

On a 5-point Likert scale, AI responses scored a 4.2 on both quality and empathy compared with scores of 3.0 on quality and 2 ...

Chronic rhinosinusitis with nasal polyps (CRSwNP) inflammatory endotypes are associated with long-term air pollutant and allergen exposure.

However, accurate polyp segmentation remains a challenging task due to the diverse morphology, varying sizes and indistinct boundaries of polyps. To address these challenges, we propose a ...

Cancer related studies were among nearly 6,000 abstracts presented at Digestive Disease Week® (DDW) 2025, including research ...

You’ve likely heard people mention that they have inherited certain health conditions from their family. These are known as ...